The investigations of efficacy and appropriate vaccination for trivalent influenza vaccine in patients with inflammatory bowel disease treated with immunomodulatory agents.
Not Applicable
- Conditions
- inflammatory bowel disease
- Registration Number
- JPRN-UMIN000009259
- Lead Sponsor
- Department of Gastroenterology, Graduate School of Medicine, Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pediatric IBD patients less than 12 years old 2) Patients who were recognized as inadequacy by doctor 3) Patients who had past history of adverse event for vaccination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The advantage for two dose of trivalent influenza vaccination compared to single dose vaccination in elder IBD patients or IBD patients treated with anti TNF-alpha agent or immunomodulator.
- Secondary Outcome Measures
Name Time Method The comparison of the efficacy for trivalent influenza vaccination between IBD patients treated with immunomodulatory agents and healthy controls.